Clinical Trial Update: Enzyme Replacement Therapy in Fabry Disease

View source ↗

Summary

The clinical trial NCT00149318 evaluating enzyme replacement therapy for Fabry disease sponsored by the Mario Negri Institute has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Enzyme Replacement Therapy (enzyme replacement therapy)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Fabry Disease | Status: TERMINATED